Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ChampionX Corp C.CHX


Primary Symbol: CHX

ChampionX Corporation is engaged in offering chemistry solutions, artificial lift systems, and engineered equipment and technologies that help companies drill for and produce oil and gas. The Company’s Production Chemical Technologies segment offers products and services that cover a range of onshore, offshore, and oil sands chemical solutions in production and midstream operations. Its Production & Automation Technologies segment offers products, technologies, and services that facilitate the extraction of oil and gas through artificial lift and digital automation applications. It designs, manufactures, markets a full range of artificial lift equipment, end-to-end automation, and digital solutions, and other production equipment and emissions monitoring solutions. Its Drilling Technologies segment offers polycrystalline diamond cutter (PDC) inserts, bearings, valves, and mining tools. Its Reservoir Chemical Technologies segment offers chemistry-oriented solutions and technologies.


NDAQ:CHX - Post by User

Comment by Dachs1on May 16, 2017 10:24am
89 Views
Post# 26249220

RE:Great News

RE:Great NewsVery good news! I am really look forward to see the prototype and to learn more about the FDA approval process (“510(k)”). A bit more investor relations would not hurt either. 


"We are very excited to move into the assembly and packaging phase following the completion of the cartridge receptor. Agile's rapid prototyping capabilities make them an ideal partner in this final stage of prototype development," said Ash Kaushal, president and chief executive officer of ChroMedX.
Read more at https://www.stockhouse.com/companies/bullboard/c.chx/chromedx-corp?postid=26219921#XVIH2TLWr6AeH46p.99


<< Previous
Bullboard Posts
Next >>